A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress
Authors:
- Peter W. HellingsPHPeter W. Hellings
- Antonella MuraroAMAntonella Muraro
- Wytske FokkensWFWytske Fokkens
- Joaquim MullolJMJoaquim Mullol
- Claus BachertCBClaus Bachert
- G. Walter CanonicaGCG. Walter Canonica
- David PriceDPDavid Price
- Nikos PapadopoulosNPNikos Papadopoulos
- Glenis ScaddingGSGlenis Scadding
- Gerd RaspGRGerd Rasp
- Pascal DemolyPDPascal Demoly
- Ruth MurrayRMRuth Murray
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 5 (1) , 1-5
Abstract
Background: The concept of control is gaining importance in the field of allergic rhinitis (AR), with a visual analogue scale (VAS) score being a validated, easy and attractive tool to evaluate AR symptom control. The doctors’ perception of a VAS score as a good tool for evaluating AR symptom control is unknown, as is the level of AR control perceived by physicians who treat patients.Methods: 307 voluntarily selected physicians attending the annual (2013) European Academy of Allergy and Clinical Immunology (EAACI) meeting completed a digital survey. Delegates were asked to (1) estimate how many AR patients/week they saw during the season, (2) estimate the proportion of patients they considered to have well‐, partly‐ and un‐controlled AR, (3) communicate how they gauged this control and (4) assess how useful they would find a VAS as a method of gauging control. 257 questionnaires were filled out completely and analysed.Results: EAACI delegates reported seeing 46.8 [standard deviation (SD) 68.5] AR patients/week during the season. They estimated that 38.7 % (SD 24.0), 34.2 % (SD 20.2) and 20.0 % (SD 16.34) of their AR patients had well‐controlled (no AR symptoms), partly‐controlled (some AR symptoms), or un‐controlled‐(moderate/severe AR symptoms) disease despite taking medication [remainder unknown (7.1 %)]. However, AR control was assessed in many ways, including symptom severity (74 %), frequency of day‐ and night‐time symptoms (67 %), activity impairment (57 %), respiratory function monitoring (nasal and/or lung function; 40 %) and incidence of AR exacerbations (50 %). 91 % of delegates felt a simple VAS would be a useful tool to gauge AR symptom control.Conclusions: A substantial portion of patients with AR are perceived as having uncontrolled or partly controlled disease even when treated. A simple VAS score is considered a useful tool to monitor AR control.Keywords
Funding Information
- Meda
This publication has 21 references indexed in Scilit:
- Integrated care pathways for airway diseases (AIRWAYS-ICPs)European Respiratory Journal, 2014
- Validation of Control of Allergic Rhinitis and Asthma Test for Children (CARATKids) – a prospective multicenter studyPediatric Allergy and Immunology, 2014
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitusCochrane Database of Systematic Reviews, 2014
- Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary careClinical & Experimental Allergy, 2013
- Specialist‐based treatment reduces the severity of allergic rhinitisClinical & Experimental Allergy, 2013
- Assessment of disease control in allergic rhinitisClinical and Translational Allergy, 2013
- Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?Allergy, 2012
- Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over timeClinical and Translational Allergy, 2012
- Uncontrolled allergic rhinitis during treatment and its impact on quality of life: A cluster randomized trialJournal of Allergy and Clinical Immunology, 2010
- Original article: Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelinesAllergy, 2007